Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × ITCH × Aprepitant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 13 Nausea 11 Neoplasms 3 Leukemia, Myeloid, Acute 2 Carcinoma, Non-Small-Cell Lung 2 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Radiation Injuries 1 Pruritus 1 Postoperative Nausea and Vomiting 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 ITCH 1 Hematologic Diseases 1 Head and Neck Neoplasms 1 Glioma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Bile Duct Neoplasms 1

Interventions

fexofenadine 1 Prednisone 1 Aprepitant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01683552 2012-09-12

AprepIt

Campus Bio-Medico University

Phase 2 Completed

ITCH

Data powered by HemOnc (CC BY 4.0) Colophon ⚡